Engineered CHO cells for production of diverse, homogeneous glycoproteins.
Nat Biotechnol
; 33(8): 842-4, 2015 Aug.
Article
em En
| MEDLINE
| ID: mdl-26192319
ABSTRACT
Production of glycoprotein therapeutics in Chinese hamster ovary (CHO) cells is limited by the cells' generic capacity for N-glycosylation, and production of glycoproteins with desirable homogeneous glycoforms remains a challenge. We conducted a comprehensive knockout screen of glycosyltransferase genes controlling N-glycosylation in CHO cells and constructed a design matrix that facilitates the generation of desired glycosylation, such as human-like α2,6-linked sialic acid capping. This engineering approach will aid the production of glycoproteins with improved properties and therapeutic potential.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Proteínas Recombinantes
/
Glicoproteínas
/
Engenharia de Proteínas
Limite:
Animals
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article